These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 19226538)

  • 1. A preliminary study of human paraoxonase and PON 1 L/M55-PON 1 Q/R 192 polymorphisms in Turkish patients with coronary artery disease.
    Kaman D; Ilhan N; Metin K; Akbulut M; Ustündağ B
    Cell Biochem Funct; 2009 Mar; 27(2):88-92. PubMed ID: 19226538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
    Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis.
    Rea IM; McKeown PP; McMaster D; Young IS; Patterson C; Savage MJ; Belton C; Marchegiani F; Olivieri F; Bonafe M; Franceschi C
    Exp Gerontol; 2004 Apr; 39(4):629-35. PubMed ID: 15050299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
    Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM
    Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
    Ozkök E; Aydin M; Babalik E; Ozbek Z; Ince N; Kara I
    Med Sci Monit; 2008 Oct; 14(10):CR536-42. PubMed ID: 18830194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease.
    Balcerzyk A; Zak I; Krauze J
    Arch Med Res; 2007 Jul; 38(5):545-50. PubMed ID: 17560461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.
    Agachan B; Yilmaz H; Karaali Z; Isbir T
    Cell Biochem Funct; 2004; 22(3):163-8. PubMed ID: 15124181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human paraoxonase gene polymorphisms and coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
    Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome.
    Koubaa N; Nakbi A; Hammami S; Attia N; Mehri S; Ben Hamda K; Ben Farhat M; Miled A; Hammami M
    Clin Biochem; 2009 Jun; 42(9):771-6. PubMed ID: 19269283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease].
    Taşkiran P; Cam SF; Sekuri C; Tüzün N; Alioğlu E; Altintaş N; Berdeli A
    Turk Kardiyol Dern Ars; 2009 Oct; 37(7):473-8. PubMed ID: 20098041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
    Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between paraoxonase1-192 polymorphism and activity with coronary artery disease.
    Mohamed RH; Mohamed RH; Karam RA; Abd El-Aziz TA
    Clin Biochem; 2010 Apr; 43(6):553-8. PubMed ID: 20026099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine.
    Yıldırım S; Akar S; Kuyucu M; Yıldırım A; Dane S; Aygül R
    Cell Biochem Funct; 2011 Oct; 29(7):549-54. PubMed ID: 21755523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variations of the apolipoprotein B gene in Turkish patients with coronary artery disease.
    Duman BS; Türkoğlu C; Akpinar B; Güden M; Vertii A; Cağatay P; Günay D; Sevim Büyükdevrim A
    Ann Hum Biol; 2005; 32(5):620-9. PubMed ID: 16316917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes.
    Sampson MJ; Braschi S; Willis G; Astley SB
    Clin Sci (Lond); 2005 Aug; 109(2):189-97. PubMed ID: 15853770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase variants relate to 10-year risk in coronary artery disease: impact of a high-density lipoprotein-bound antioxidant in secondary prevention.
    Regieli JJ; Jukema JW; Doevendans PA; Zwinderman AH; Kastelein JJ; Grobbee DE; van der Graaf Y
    J Am Coll Cardiol; 2009 Sep; 54(14):1238-45. PubMed ID: 19778663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the association between paraoxonase1 55 Met/Leu, paraoxonase2 148 Ala/Gly and manganese superoxide dismutase (MnSOD) 9 Ala/Val genetic polymorphisms and coronary heart disease].
    Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):808-13. PubMed ID: 17299970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The paraoxonase gene polymorphism in stroke patients and lipid profile.
    Shin BS; Oh SY; Kim YS; Kim KW
    Acta Neurol Scand; 2008 Apr; 117(4):237-43. PubMed ID: 17854416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
    Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
    Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between PON 1 polymorphisms, PON activity and diabetes complications.
    Hofer SE; Bennetts B; Chan AK; Holloway B; Karschimkus C; Jenkins AJ; Silink M; Donaghue KC
    J Diabetes Complications; 2006; 20(5):322-8. PubMed ID: 16949520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.